BBCMF (Lir Life Sciences) Total Current Liabilities: $0.06 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Total Current Liabilities?

Lir Life Sciences BBCMF -80.00% 15 Total Current Liabilities is $0.06 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Lir Life Sciences's total current liabilities for the quarter that ended in Jan. 2026 was $0.06

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Lir Life Sciences Total Current Liabilities Related Terms

Lir Life Sciences Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Total Current Liabilities Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Total Current Liabilities
0.17 0.15

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Current Liabilities Get a 7-Day Free Trial 0.00 0.15 0.30 0.04 0.06
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Lir Life Sciences's Total Current Liabilities for the fiscal year that ended in Apr. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.145+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.15

Lir Life Sciences's Total Current Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.057+0
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of $0.06 Mil mean?
Lir Life Sciences (BBCMF) has a Total Current Liabilities of $0.06 Mil as of Jan. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Lir Life Sciences and its competitors.
Is Lir Life Sciences' Total Current Liabilities too high?
Lir Life Sciences' current Total Current Liabilities is $0.06 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Total Current Liabilities compare to VRTX and REGN?
Lir Life Sciences' Total Current Liabilities of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Biotechnology company?
A good Total Current Liabilities depends on the Biotechnology industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Lir Life Sciences and its competitors. Lir Life Sciences's current Total Current Liabilities is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Total Current Liabilities of $0.06 Mil. The current Total Current Liabilities is $0.06 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Total Current Liabilities is $0.06 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price